- 米国企業
- Cue Biopharma, Inc.
Cue Biopharma, Inc.CUE
時価総額
$7716.1万
PER
| 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
| Collaboration revenue | - | 3 | 3 | 15 | 1 |
| General and administrative | - | 13 | 15 | 17 | 16 |
| Research and development | - | 27 | 34 | 41 | 39 |
| Gain On Right Of Use Asset Termination | - | - | - | - | 276,633 |
| Total operating expenses | - | 40 | 48 | 59 | 54 |
| Loss from operations | - | -36,769,247 | -45,042,585 | -43,712,073 | -53,224,809 |
| Interest income | - | 418,712 | 463,914 | 45,898 | 928,242 |
| Interest expense | - | - | - | - | -713,815 |
| Total other income | - | 482,790 | 463,914 | 45,898 | 214,427 |
| Loss before provision for income taxes | - | -36,286,457 | -44,578,671 | -43,666,175 | -53,010,382 |
| Provision for income taxes | - | 412,500 | 206,250 | 495,000 | - |
| Net loss | -38,980,313 | -36,698,957 | -44,784,921 | -44,161,175 | -53,010,382 |
| Unrealized (loss) gain from available-for-sale securities | - | 637 | 17,452 | -7,131 | -95,873 |
| Comprehensive loss | - | -36,698,320 | -44,767,469 | -44,168,306 | -53,106,255 |
| Earnings Per Share, Basic | - | - | - | - | -1.49 |
| Earnings Per Share, Diluted | - | - | - | - | -1.49 |